Skip Navigation



European Heart Journal Advance Access published online on December 9, 2004
European Heart Journal, doi:10.1093/eurheartj/ehi040
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
26/2/173    most recent
ehi040v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Modesto, K. M.
Right arrow Articles by Abraham, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modesto, K. M.
Right arrow Articles by Abraham, T. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2004; all rights reserved.

Clinical research

Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques

Karen M. Modesto 1, Angela Dispenzieri 2, Sanderson A. Cauduro 1, Martha Lacy 2, Bijoy K. Khandheria 1, Patricia A. Pellikka 1, Marek Belohlavek 1, James B. Seward 1, Robert Kyle 2, A. Jamil Tajik 1, Morie Gertz 2, and Theodore P. Abraham 3*

1 Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA
2 Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA
3 Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA; Johns Hopkins University, 600 North Wolfe Street, Carnegie 568, Baltimore, MD 21287, USA

* To whom correspondence should be addressed.
Theodore P. Abraham, E-mail: tabraha3{at}jhmi.edu


  Abstract

Aims To assess left atrial (LA) function and determine the prevalence of LA dysfunction in AL amyloidosis (AL) using conventional and strain echocardiography.

Methods and results LA ejection fraction, LA filling fraction, LA ejection force, peak LA systolic strain rate (LAsSR), and LA systolic strain (LA {varepsilon}) were determined in 95 AL patients (70 with and 25 without echocardiographic evidence of cardiac involvement, abbreviated CAL and NCAL, respectively), 30 age-matched controls (CON), and 20 patients with diastolic dysfunction and LA dilatation (DD). Peak LAsSR >2 standard deviations below mean CON value was used as the cut-off for normal LA function. LA ejection fraction was lower in CAL when compared with CON (40.4 ± 13.6 vs. 67.0 ± 6%, P = 0.01). Left atrial septal strain rate and strain were lower in CAL (0.8 ± 0.5s-1 and 5.5 ± 4%, respectively) compared with CON (1.8 ± 0.8s-1 and 14 ± 4%, respectively, P = <0.0001), NCAL (1.6 ± 0.8s-1 and 13 ± 7%, respectively, P < 0.0001) and DD (1.3 ± 0.4s-1 and 10 ± 2%, respectively, P < 0.0001). Based on peak LA systolic strain rate criteria, the cut-off values for normal LA function were -1.1s-1 and -1.05s-1 for lateral and septal walls. Using these criteria, LA dysfunction was identified in 32% (lateral LA criteria) and 60% (septal LA criteria) of CAL patients. Lateral and septal LAsSR were lower in CAL patients with vs. those without symptoms of heart failure. Inter- and intra-observer agreement was high for LA strain echocardiography.

Conclusion LA function assessment using strain echocardiography is feasible with low intra- and inter-observer variability. LA dysfunction is observed in AL patients without other echocardiographic features of cardiac involvement and may contribute to cardiac symptoms in CAL.

Keywords: Amyloidosis; Strain; Atrial function; Echocardiography.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
D. Feng, I. S. Syed, M. Martinez, J. K. Oh, A. S. Jaffe, M. Grogan, W. D. Edwards, M. A. Gertz, and K. W. Klarich
Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis
Circulation, May 12, 2009; 119(18): 2490 - 2497.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc ImagingHome page
M. Kurt, J. Wang, G. Torre-Amione, and S. F. Nagueh
Left Atrial Function in Diastolic Heart Failure
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 10 - 15.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. B. Selvanayagam, P. N. Hawkins, B. Paul, S. G. Myerson, and S. Neubauer
Evaluation and Management of the Cardiac Amyloidosis
J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2101 - 2110.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. P. Abraham, V. L. Dimaano, and H.-Y. Liang
Role of Tissue Doppler and Strain Echocardiography in Current Clinical Practice
Circulation, November 27, 2007; 116(22): 2597 - 2609.
[Full Text] [PDF]

Home page
 CirculationHome page
D. Feng, W. D. Edwards, J. K. Oh, K. Chandrasekaran, M. Grogan, M. W. Martinez, I. I. Syed, D. A. Hughes, J. A. Lust, A. S. Jaffe, et al.
Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis
Circulation, November 20, 2007; 116(21): 2420 - 2426.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. H. Falk
Diagnosis and Management of the Cardiac Amyloidoses
Circulation, September 27, 2005; 112(13): 2047 - 2060.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.